Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cessation and reduction in alcohol consumption and misuse after psychedelic use
Albert Garcia‐Romeu, Alan K. Davis, Fire Erowid, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1088-1101
Closed Access | Times Cited: 222

Showing 26-50 of 222 citing articles:

Insight and the selection of ideas
Ruben Laukkonen, Margaret E. Webb, Carola Salvi, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 153, pp. 105363-105363
Open Access | Times Cited: 22
Effects of DMT on mental health outcomes in healthy volunteers
Christopher Timmermann, Richard J. Zeifman, David Erritzøe, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Giving Consent to the Ineffable
Daniel Villiger
Neuroethics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 10
An Integrated theory of false insights and beliefs under psychedelics
H. T. McGovern, Hilary Jane Grimmer, Manoj K. Doss, et al.
Communications Psychology (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 10
Acute subjective effects in LSD- and MDMA-assisted psychotherapy
Yasmin Schmid, Peter Gasser, Peter Oehen, et al.
Journal of Psychopharmacology (2020) Vol. 35, Iss. 4, pp. 362-374
Closed Access | Times Cited: 62
Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review
Alec James Divito, Robert F Leger
Molecular Biology Reports (2020) Vol. 47, Iss. 12, pp. 9791-9799
Closed Access | Times Cited: 54
Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals
Drummond E-Wen McCulloch, Martin Bruun Madsen, Dea Siggaard Stenbæk, et al.
Journal of Psychopharmacology (2021) Vol. 36, Iss. 1, pp. 74-84
Open Access | Times Cited: 50
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 50
The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects
Malin V. Uthaug, Alan K. Davis, Trevor Forrest Haas, et al.
Journal of Psychopharmacology (2021) Vol. 36, Iss. 3, pp. 309-320
Open Access | Times Cited: 49
A narrative synthesis of research with 5-MeO-DMT
Anna O. Ermakova, Fiona Dunbar, James Rucker, et al.
Journal of Psychopharmacology (2021) Vol. 36, Iss. 3, pp. 273-294
Open Access | Times Cited: 47
Increases in Psychological Flexibility Mediate Relationship Between Acute Psychedelic Effects and Decreases in Racial Trauma Symptoms Among People of Color
Alan K. Davis, Yitong Xin, Nathan D. Sepeda, et al.
Chronic Stress (2021) Vol. 5
Open Access | Times Cited: 46
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy
Kate Corrigan, Maeve Haran, Conor McCandliss, et al.
Irish Journal of Medical Science (1971 -) (2021) Vol. 191, Iss. 3, pp. 1385-1397
Open Access | Times Cited: 45
Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis
Robert F Leger, Ellen M. Unterwald
Journal of Psychopharmacology (2021) Vol. 36, Iss. 1, pp. 20-30
Closed Access | Times Cited: 43
Counselors’ attitudes toward psychedelics and their use in therapy
Benjamin Hearn, Michael D. Brubaker, George B. Richardson
Journal of Counseling & Development (2022) Vol. 100, Iss. 4, pp. 364-373
Open Access | Times Cited: 31
Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research
Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, et al.
Addiction Neuroscience (2022) Vol. 3, pp. 100025-100025
Open Access | Times Cited: 31
Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies
Javier Calleja‐Conde, José Á. Morales-García, Víctor Echeverry‐Alzate, et al.
Addiction Biology (2022) Vol. 27, Iss. 6
Open Access | Times Cited: 31
Naturalistic Psychedelic Use: A World Apart from Clinical Care
Nicolas G. Glynos, Christopher W. Fields, Julie Barron, et al.
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 4, pp. 379-388
Closed Access | Times Cited: 30
Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects
Anders S. Olsen, Anders Lykkebo-Valløe, Brice Ozenne, et al.
NeuroImage (2022) Vol. 264, pp. 119716-119716
Open Access | Times Cited: 30
Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users
Baptiste Fauvel, Samuli Kangaslampi, Lana Strika-Bruneau, et al.
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 2, pp. 170-179
Closed Access | Times Cited: 29
Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study
Grant Jones, Matthew K. Nock
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism
Jennifer Mitchell, B. Anderson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 96-103
Open Access | Times Cited: 21
The Canadian Psychedelic Survey: Characteristics, Patterns of Use, and Access in a Large Sample of People Who Use Psychedelic Drugs
Stephanie Lake, Philippe Lucas
Psychedelic Medicine (2023) Vol. 1, Iss. 2, pp. 98-110
Closed Access | Times Cited: 19
Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.
Gabrielle Agin-Liebes, Elizabeth M. Nielson, Michael A. Zingman, et al.
Psychology of Addictive Behaviors (2023) Vol. 38, Iss. 1, pp. 101-113
Closed Access | Times Cited: 17
With great power comes great vulnerability: an ethical analysis of psychedelics’ therapeutic mechanisms proposed by the REBUS hypothesis
Daniel Villiger, Manuel Trachsel
Journal of Medical Ethics (2023) Vol. 49, Iss. 12, pp. 826-832
Open Access | Times Cited: 16
Psychedelics and the ‘inner healer’: Myth or mechanism?
Joseph Peill, M. Marguilho, David Erritzøe, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 417-424
Open Access | Times Cited: 7

Scroll to top